Abstract
Although haloperidol is mainly used for the medical treatment of delirium in cancer patients, there are no universally accepted guidelines for its usage. We accordingly assessed the usefulness in managing delirium of a haloperidol treatment regimen in ten delirious cancer patients. The results of this preliminary study suggest that, in the management of delirium, appropriate usage of haloperidol on the first day is important as it affects the dosage thereafter.
This is a preview of subscription content, log in via an institution to check access.
References
Adams F, Fernandez F, Andersson BS (1986) Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics 27:33–37
Fleishman S, Lesko ML (1989) Delirium and dementia. In: Holland JC, Rowland JH (eds) Handbook of psychooncology. Oxford University Press, New York, pp 342–355
Lipowski ZJ (1990) Delirium — acute confusional states. Oxford University Press, New York
Massie MJ, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050
Moulaert P (1989) Treatment of acute nonspecific delirium with I.V. haloperidol in surgical intensive care patients. Acta Anaesth Belg 40:183–186
Peterson LG, Leipman M, Bongar B (1987) Psychotropic medications in patients with cancer. Gen Hosp Psychiatry 9:313–323
Stiefel F, Fainsinger R, Bruera E (1992) Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 7:94–98
Trzepacz PT, Baker RW, Greenhouse J (1988) A symptom rating scale for delirium. Psychiatry Res 23:89–97
Weinrich S, Sarna L (1994) Delirium in the older person with cancer. Cancer 74:2079–2091
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Akechi, T., Uchitomi, Y., Okamura, H. et al. Usage of haloperidol for delirium in cancer patients. Support Care Cancer 4, 390–392 (1996). https://doi.org/10.1007/BF01788847
Issue Date:
DOI: https://doi.org/10.1007/BF01788847